Change of Management in Evonik’s Health & Nutrition Business Unit

16-Mar-2009 - Germany

Dr. Hans-Josef Ritzert, head of Evonik Industries AG’s catalysts Business Line, will take over management of the Exclusive Synthesis & amino acids Business Line effective April 1, 2009. His predecessor, Dr. Rudolf Hanko, will leave the company on May 1, 2009, to assume the position of CEO at Siegfried Holding, Zofingen, Switzerland, immediately.

To become acquainted with his new function, Dr. Ritzert will hand over management of the Catalysts Business Line to Dr. Wilfried Eul as early as April 1. Eul was responsible for managing Rexim´s business for Pharmaceutical Amino Acids and headed the Asia Region for Exclusive Synthesis & Amino Acids.

Until further notice, Dr. Ritzert will perform Dr. Eul’s job as head of Rexim and regional president.

Other news from the department people

Most read news

More news from our other portals

Discover the latest developments in battery technology!